Navigation Links
MacroGenics Appoints New Vice President of Business Development
Date:3/26/2009

al partners for our innovative antibody platform technologies and large library of antibodies that target cancers," stated Dr. Koenig.

About MacroGenics, Inc.

Founded in 2000, MacroGenics is a private, fully-integrated biotechnology company headquartered in Rockville, Maryland that focuses on the development, manufacture and commercialization of immunotherapeutics for autoimmune disorders, cancer and infectious diseases. In October 2007, MacroGenics, Inc. and Eli Lilly and Company announced a global strategic alliance to develop and commercialize teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next-generation anti-CD3 molecules for use in the treatment of autoimmune diseases. Teplizumab is currently being studied in the PROTEGE trial, a global pivotal Phase II/III clinical trial for individuals with recent-onset type 1 diabetes (for more information, please visit www.protegediabetes.org). In July 2008, MacroGenics acquired Raven Biotechnologies, Inc., a privately held biotechnology company in South San Francisco, California, focused on the discovery and development of monoclonal antibody therapeutics for oncology through its cancer stem-like cell program. MacroGenics' proprietary DART (Dual Affinity Re-Targeting) and Fc-optimization technologies offer ways to improve the function of antibodies and similar molecules. For more information about MacroGenics, please visit www.macrogenics.com.

Statements made in this news release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "expects," "believes," "intends," and similar expressions are intended to identify forward-looking statements. Actual results may differ materially from those projected in any forward-l
'/>"/>

SOURCE MacroGenics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MacroGenics Raises $25M in Series D-2 Financing
2. MacroGenics Acquires Raven Biotechnologies
3. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
4. DOR BioPharma Appoints Gregg Lapointe, CPA, MBA, to its Board of Directors
5. DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
6. Veridiam Appoints Andrew Gale as Chief Executive Officer
7. Pharmaxis Appoints French Distributor for Aridol(TM)
8. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
9. PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors
10. China-Biotics, Inc. Appoints New Chief Financial Officer
11. Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v.25/PRNewswire/--Reportlinker.comannouncesthatane..., BrazilBioethanolMarketAnalysisandForecaststo2...razil-Bioethanol-Market-Analysis-and-Forecasts-to-...Forecaststo2013 ,, Summary ,, Thereportpro...anolmarketandtheBrazilbioethanolmarketinparticular...
(Date:11/24/2009)... The New York investment bank KTA Capital,s...greed an AU$6.7 mil convertible note private place...te placement was arranged by KTA Capital as Neuren... New York (PRWEB) November 23, 2...A Capital, LLC ("KTA Capital") has annou...
(Date:11/24/2009)... Health care employment grew by 29,000 jo...to show consistent growth during the U.S. recessio... in trouble, and health systems are coming closer ...ad of just administrators. , ...yment continued growing in October despite the she...
(Date:11/24/2009)...v.24/PRNewswire/--BlueMarbleEnergyCorp.announcedto...ority(OPDA)wererecentlyawarded$2millionbyWashingto...inaprivate/publicpartnershiptoconstructthestate,sf...,WA. ,, "Thisinvestmentwillsignificantlyspeedth...stoLincolnCounty,"saidBlueMarbleEnergyCEOKellyOgil...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...d.,(TASE: ITGI) announced today the first commerci...ardium Covered Stent (PCS) in the UK, Over and Un... tissue,designed to set a barrier between the coro...ed for situations such as degenerated Saphenous Ve...first Over and Under(R) PCS commercial implantatio...
...affect patient response to ...2 Roche and DxS Ltd. have,signed an exclusive dis...Mutation Test and TheraScreen EGFR 29 Mutation Tes...her clinically relevant factors, to aid,doctors in...rom a specific,cancer therapy based on their mutat...
...s,area within SAFC(R), a member of the Sigma-Aldri...oduction of the OM700, a bubbler that offers,custo... precursor delivery,for larger lot sizes, enabling...creased safety controls., The OM700 offers reliab...tive organometallic precursors, such as trimethylg...
Other Biology Technology:Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability 2Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 2Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 3SAFC Hitech Introduces Large Scale Bubbler for Compound Semiconductor Production 2SAFC Hitech Introduces Large Scale Bubbler for Compound Semiconductor Production 3
(Date:11/26/2009)...t in eight European countries has shown that closi...andemic could have a significant role in reducing ...pen access journal BMC Infectious Diseases compa... weekends/holidays, finding that they were reduced...t and Antwerp University, Belgium, led a team of E...
(Date:11/25/2009)...produced in the stomach, may be used to boost resi... disease, Yale School of Medicine researchers repo...Journal of Neuroscience . , Parkinson,s disease ... an area of the midbrain known as the substantia n.... Reduced production of dopamine in late-stage Pa...
(Date:11/25/2009)...a lifetime, the heart pumps some 250 million liter...is, the muscle fibers of the heart have to be extr...lfgang Rottbauer, vice chair of the Department of ...airman: Prof. Dr. H. A. Katus), has discovered a p...e smallest muscular unit, the sarcomere. In cooper...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 1SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 2OAG Releases Prototype for Pandemic Disease Planning and Management 56336 1OAG Releases Prototype for Pandemic Disease Planning and Management 56336 2OAG Releases Prototype for Pandemic Disease Planning and Management 56336 3Restorative Therapies Inc Receives FDA Clearance for RT300 Enhancements 56333 1Restorative Therapies Inc Receives FDA Clearance for RT300 Enhancements 56333 2Restorative Therapies Inc Receives FDA Clearance for RT300 Enhancements 56333 3
... Department of Energys Office of Science today rel...publication, Facilities for the Future of Science:...made significant progress in deploying the scienti...tes needs to capture world scientific leadership, ...partments missions. , When it was published four ...
...One of the World,s Leading Software ..., Oct. 10 (OTC Bulletin,Board: CICI) Communicatio...lier of electronic signature solutions for busines... the recognized leader in biometric signature,veri...rd time in Software,Magazine,s Software 500 rankin...
...angladesh finds that folic acid supplements can dr...ls chronically exposed to arsenic-contaminated dri...aturally present in some soils and water. Arsenic...icant public health problem in at least 70 countri...o parts of the United States. Chronic arsenic exp...
Other Biology News:DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 2DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 3DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 4DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 5CIC Again Named to Software Magazine's Annual Prestigious Software 500 List 2CIC Again Named to Software Magazine's Annual Prestigious Software 500 List 3Folic acid lowers blood arsenic levels in Bangladesh 2Folic acid lowers blood arsenic levels in Bangladesh 3
Mouse Anti-Human XPC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Lck, phospho (Tyr192) Polyclonal Antibody, Unconjugated from Abcam
Anti-7H6 Antigen (tight-junction associated protein antigen) Monoclonal Antibody, Unconjugated, Clone 7H6 from Cell Sciences
Goat Anti-Ephrin B2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: